22510 N 18th Drive
Amnio Technology, LLC is a global leader in the development and use of amnion-derived technologies. Amniotic tissue contain key growth factors, cytokines, amino acids, carbohydrates, hyaluronic acid, extracellular matrix (ECM) proteins, and cellular components recognized as intrinsic to the complex wound healing process. Published studies on the benefits and efficacy of amniotic tissue in wounds date back over 100 years. Amnio Technology is focused on optimizing the regenerative potential and clinical use of these unique tissues.
CEO: Ethan Minkin
CSO: Christian Beaudry
CFO: Kent Krueger
Please click here for Amnio Technology's job opportunities.
Please click here for Amnio Technology's products.